Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Generating extra cash can help alleviate your debt burden. Explore various options to boost your income effectively.
20,698 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
In 2025, Sophia Genetics is at a crossroads between expanding its software platform and tightening its financial disc...
Over the years, my approach to collecting rent transformed from paper-led reminders to a streamlined, tech-backed sys...
Broadcom reported a strong Q1 FY2026 with AI-driven growth and a deep backlog, setting up a targeted, three-year broa...
KLAC stock has captured investor attention as semiconductor tool demand shifts with AI and data growth. This guide br...
Adobe has fallen sharply in 2026, prompting a rotation debate toward Alphabet as AI momentum and big-cap investments ...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
Palantir tops $300 billion in market value as Q1 2026 results reveal record growth and expanding margins. The milesto...
In 2026, two retail powerhouses—Chewy and Walmart—face very different growth paths. This guide dissects their models,...
Five dividend-paying giants have sat on Goldman Sachs' Conviction List the longest, underscoring steady income as mar...
C3.ai has faced a dramatic 2026 drop, leaving investors wondering if the stock is a hidden bargain or a value trap. T...
Fresh insider purchases in three battered names point to growing belief that cash flow and demand visibility can rebo...